jetcityimage/iStock Editorial via Getty Images Eli Lilly (NYSE:LLY) has received regulatory approval to market its
aprott Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps
AlexLMX/iStock via Getty Images The U.S. FDA will offer feedback and other assistance to states
wellesenterprises Sales of Eli Lilly’s blockbuster GLP-1/GIP meds Zepbound and Mounjaro, which contain tirzepatide and
JHVEPhoto The Food and Drug Administration (FDA) has cleared Lumipulse G for U.S. commercialization as
JHVEPhoto/iStock Editorial via Getty Images Novo Nordisk (NVO) (OTCPK:NONOF) appears to have forced its CEO,
Deepak Verma Although some individuals might find taking a medicine as a pill more palatable
jetcityimage/iStock Editorial via Getty Images While many pharma and biotech companies developing drugs to treat
If President Trump’s threat to impose tariffs on pharmaceutical products goes through, it would have
Richard Drury Sanofi (NASDAQ:SNY) will invest at least $20B in the U.S. through 2030, focusing